Top 10 Stock Picks for October 2025: Best Funds to Buy Now for Growth, Safety, and Diversification

By -

With the Federal Reserve maintaining its rate-cutting trajectory into October 2025 amid heightened market volatility and sector rotation, opportunities are emerging in small caps, semiconductors/AI, value stocks, and gold miners as hedges. Based on recent analyses from Zacks, Morningstar, Yahoo Finance, and ETF experts, we've compiled a forward-looking list of 10 recommendations expected to capitalize on these trends through the end of October and into Q4. Selections emphasize high-conviction picks with upward earnings revisions, undervaluation, and momentum in resilient sectors.

Top 10 Stocks and ETFs Poised to Outperform in October 2025

Below, we've incorporated recent performance data (YTD) for context on their trajectory.

Top 10 Stocks to Watch in October 2025

Drawing from recent expert analyses and market forecasts, these stocks are selected for their strong momentum, earnings potential, and sector tailwinds in areas like technology, commodities, consumer staples, and AI amid ongoing rate cuts and economic resilience.

These stocks have shown strong year-to-date performance in 2025, indicating potential to continue outperforming shortly:

1. Robinhood Markets, Inc. (HOOD)

  • Recent YTD Performance: +285% year-to-date with a 561% gain over 1 year; recent surge driven by S&P 500 inclusion and strong revenue growth. (TradingView)
  • Recent Market Capitalisation: $132 B
Robinhood vs Palantir: Both are high-growth tech stocks that have delivered massive returns in 2025—Robinhood up ~421% (1Y) and Palantir up ~382% (1Y) —fueled by momentum in retail trading and AI/data analytics, respectively. However, traditional metrics like price-to-earnings (P/E) and price-to-sales (P/S) ratios reveal stark differences. Palantir trades at significantly higher multiples, suggesting it is more overvalued relative to current and forward earnings/sales, even accounting for its growth narrative. Analysts often describe Palantir's valuation as "insanely expensive" or "overhyped," while Robinhood's is elevated but more grounded in fintech recovery.

2. Newmont Corp. (NEM)

  • Recent Performance: YTD +128%, 1M +10%.
  • Mining (Safety/Hedge): Gold leader benefiting from record prices and safe-haven demand; Zacks #1 Rank with 67% EPS growth forecast. 
  • Recent Market Capitalisation: $95 B

3. Seagate Technology (STX)

  • Recent Performance: YTD +189%, 1M +8.7%.
  • Data Storage (Growth): AI-driven storage and AI data center demand; top YTD performer with strong forecasts. 
  • Recent Market Capitalisation: $53 B

4. Palantir Technologies (PLTR)

  • YTD - October 2025 range: +120 - 135% (TradingView)
  • Recent Market Capitalisation: $410 B
Palantir trades at significantly higher multiples, suggesting it is more overvalued relative to current and forward earnings/sales, even accounting for its growth narrative.

5. Western Digital (WDC)

  • Recent Performance: YTD +192%, 1M +7%.
  • Data Storage (Growth): Storage for AI boom; undervalued with earnings rebound. 
  • The recent price surge is driven by strong demand for data storage in AI and cloud sectors, with analysts maintaining a Buy consensus and potential for further upside.
  • Recent Market Capitalisation: $45 B

6. Micron Technology (MU)

  • Recent Performance: YTD +123%, 1M +10%.
  • Semiconductors (Growth): Memory chips for AI data centers; Zacks #1 Rank, 50%+ EPS growth expected. 

7. GE Vernova (GEV)

  • Recent Performance: YTD +86.4%, 1M +10.5%.
  • Energy tech spin-off with renewable focus; 86.4% YTD driven by green energy transition. 

8. General Electric (GE)

  • +65.0% (YTD)

9. CVS Health (CVS)

  • +63.0% (YTD)

10. NRG Energy (NRG)

  • +61.3% (YTD)
Related: Gold Mining Stocks and ETFs: Why They're Trouncing AI (2025)

Ranking Methodology

  • YTD Performance: Based on reported or estimated returns for 2025 (as of October 2025). Higher returns rank higher. 
  • Market Capitalisation: Used as a secondary factor for assessing stability and risk diversification, reflecting stock popularity and liquidity.
  • Data Source: TradingView

Market Outlook Drivers

  • Robinhood's strong 2025 momentum is fueled by its expanding user base, a 59.4% revenue growth rate, and inclusion in the S&P 500, driving investor confidence. It reported 26.5 million funded customers and a robust Q2 earnings beat.
  • Continued momentum in AI-related earnings is elevating technology stocks.
  • Small-cap and value stocks remain attractive but undervalued, presenting opportunity.
This curated mix of high-growth stocks like Robinhood and others provide balanced exposure to sectors poised for outperformance in October 2025.

Disclaimer

This is not financial advice. Past performance doesn’t guarantee future results. Consult a financial advisor and conduct your own research before investing.

The information presented in this article is intended for general informational purposes only and should not be construed as professional financial or investment advice. The revenue figures, company rankings, and projections are based on publicly available data, company reports, and industry estimates as of 2025. All currency conversions, where applicable, are based on annual average exchange rates.

While efforts have been made to ensure the accuracy and timeliness of the information, One Day Advisor and the article’s authors do not guarantee the completeness, reliability, or suitability of the content for any particular purpose. Readers are encouraged to verify details independently and consult qualified professionals before making any business, investment, or healthcare decisions based on the information provided.

The article may reference ongoing developments, regulatory actions, or market events that are subject to change. One Day Advisor is not responsible for any losses or damages arising from the use of this information.

References: 

Comments

Post a Comment

Pages

Archive

Show more

Popular posts from this blog

Top 10 ETF Picks for October 2025: Best Funds to Buy Now for Growth, Safety, and Diversification

By -
Image
Here are the top 10 ETF picks for October 2025, along with insights on whether they are worth considering for investment right now. This list blends global equity leaders, sector specialists in defense and metals, and broad market trackers—balancing momentum with diversification and risk management. We’ve ranked the 10 ETF picks for October 2025 based on their year-to-date (YTD) performance and Assets Under Management (AUM), using available data from the provided references and general market insights. The ranking gives weightage to YTD performance, as it reflects recent momentum, and uses AUM as another factor to gauge investor confidence and fund size. These ETFs target high-growth areas like gold mining, crypto, technology, and sustainable themes, based on top-performing indices and expert picks for Q4 momentum. These ETFs have delivered strong returns over recent months and 2025 year-to-date, spanning sectors like gold mining, uranium, defense, AI, and blockchain: Ranking Methodolo...
Read more

Top 10 Stocks and ETFs Poised to Outperform in October 2025

By -
Image
With the Federal Reserve maintaining its rate-cutting trajectory into October 2025 amid heightened market volatility and sector rotation, opportunities are emerging in small caps, semiconductors/AI, value stocks, and gold miners as hedges. Based on recent analyses from Zacks, Morningstar, Yahoo Finance, and ETF experts, we've compiled a forward-looking list of 20 recommendations (10 stocks and 10 ETFs) expected to capitalize on these trends through the end of October and into Q4. Selections emphasize high-conviction picks with upward earnings revisions, undervaluation, and momentum in resilient sectors. Below, we've incorporated recent performance data (YTD) for context on their trajectory. Top 10 Stocks to Watch in October 2025 Drawing from recent expert analyses and market forecasts, these stocks are selected for their strong momentum, earnings potential, and sector tailwinds in areas like technology, commodities, consumer staples, and AI amid ongoing rate cuts and economic r...
Read more

Top 10 ETF Picks for September 2025: Best Funds to Buy Now for Growth, Safety, and Diversification

By -
Image
Here are the top 10 ETF picks for September 2025, along with insights on whether they are worth considering for investment right now. This list blends global equity leaders, sector specialists in defense and metals, and broad market trackers—balancing momentum with diversification and risk management. We’ve ranked the 10 ETF picks for September 2025 based on their year-to-date (YTD) performance and Assets Under Management (AUM) as of September 2025, using available data from the provided references and general market insights. Since precise YTD performance and AUM figures for some ETFs (e.g., EUAD, VIG) were not fully detailed in the references, we’ve supplemented with reasonable estimates based on trends and sector performance. The ranking gives weightage to YTD performance, as it reflects recent momentum, and uses AUM as another factor to gauge investor confidence and fund size. Update: Top 10 ETF Picks for October 2025 Ranking Methodology YTD Performance: Based on reported or estim...
Read more

Top 10 Pharmaceutical Companies by Revenue and Market Cap in 2025 (September Edition)

By -
Image
Here are the top 10 pharmaceutical companies as of 2025, updated based on second quarter 2025 revenue data. AstraZeneca, Novartis and Vertex each posted 12% sales increases, offering more evidence of their upward trajectories in recent years. Credit:  fiercepharma.com Only one of the top 10 drugmakers, Eli Lilly, is expected to achieve a double-digit revenue increase by the end of 2025. Eli Lilly is projecting a robust growth of around 32% in 2025 compared to 2024, driven by strong sales of its diabetes and weight-loss drugs such as Mounjaro and Zepbound, with full-year revenue guidance between $58 billion and $61 billion ( 1 ,  2 ,  3 ). Updates: Drug Stock Rally Helps Push Dow and S&P 500 to Records — WSJ ( Oct 2, 2025 ) Eli Lilly's (LLY) shares jumped 8.6% amid reports of a drug-pricing deal between the White House and the pharmaceutical industr...
Read more

Best Gold and Silver ETFs of 2025: Should You Buy Today? (October 2025 Edition)

By -
Image
Gold and silver ETFs have shown strong performance in 2025, surpassing the S&P 500 amid inflation concerns, geopolitical tensions, and central bank buying.  With the Federal Reserve maintaining its rate-cutting trajectory into October 2025 amid heightened market volatility and sector rotation, opportunities are emerging in gold miners as hedges.  This article updates the best-performing gold and silver ETFs based on recent data, including 1-year returns, assets under management (AUM), expense ratios, and key notes, evaluating their pros, cons, and attractiveness in the current market.The best gold and silver ETFs of 2025 are noted for exceptional performance, low expense ratios, and reliable tracking of precious metals’ prices. Returns have adjusted slightly since late August due to recent price movements, but momentum remains strong with gold and silver near record highs. Here are the top options across global and key regional markets as of September 2025: Best Gold ETFs...
Read more

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights

By -
Image
As the cryptocurrency market matures in 2025, XRP ETFs have emerged as essential instruments for investors seeking regulated and accessible exposure to this dynamic digital asset. With a growing variety of futures-based and physically backed spot ETFs now available across major markets like the U.S., Canada, and Europe, understanding the nuances of these products—including their fee structures, holdings, and performance—is crucial for making informed investment decisions. This article highlights the top XRP ETFs to watch in 2025, providing deep insights into their dominating holdings, low fees, and recent market impact, all organized in a clear list format for easy navigation. Whether you are a long-term investor or an active trader, this guide will help you identify opportunities and risks in the evolving XRP ETF landscape. Update:  Top Bitcoin, Ethereum, and XRP ETFs to Watch in October 2025 : Updated Performance, AUM, and Investment Insights 1. Leading XRP ETFs in 2025 ProSha...
Read more

Stablecoins in 2025: Market Analysis, Regulatory Landscape, Adoption Trends, and Investment Opportunities

By -
Image
Executive Summary As of October 2025, stablecoins have solidified their position as a cornerstone of the digital economy, with a global market capitalization exceeding $250-280 billion and transaction volumes on track to surpass $40 trillion annually—eclipsing traditional payment networks like Visa and Mastercard combined. These USD-pegged digital assets are no longer fringe elements of cryptocurrency but are driving real-world applications in payments, remittances, and institutional finance. Regulatory clarity, particularly through the U.S. GENIUS Act signed in July 2025, has accelerated institutional adoption, while emerging markets lead in relative usage. This report expands on the transformative potential of stablecoins, highlighting market growth, key regulatory updates, adoption drivers, leading companies, and forward-looking opportunities. While holding stablecoins offers stability rather than appreciation, the ecosystem's infrastructure providers present significant upside ...
Read more

Tech and Innovation ETFs in 2025: Top Picks, Strategies, and Risks

By -
Image
As we enter the latter half of 2025, the technology sector continues to dominate global markets, driven by breakthroughs in artificial intelligence (AI), semiconductors, robotics, and cloud computing. With the S&P 500's tech component accounting for over 34% of the index and the Nasdaq-100 even more heavily weighted toward innovation-driven companies, tech and innovation ETFs offer investors a streamlined way to capitalize on these trends. These exchange-traded funds (ETFs) provide diversified exposure to high-growth areas without the need to pick individual stocks, reducing some of the inherent risks while maintaining potential for substantial returns. Update:  Top 10 Stocks and ETFs Poised to Outperform in October 2025 This comprehensive guide explores the current market landscape, key selection criteria for ETFs, top picks for 2025, portfolio-building strategies, associated risks, and forward-looking forecasts. Whether you're a beginner investor or a seasoned portfolio m...
Read more

10 Best Artificial Intelligence Stocks of 2025

By -
Image
The best artificial intelligence (AI) stocks to watch and potentially invest in for 2025 include a mix of well-established tech giants and high-growth specialized companies. Below is a brief overview of the state of AI, followed by a list of AI stocks that look promising for 2025. State Of Artificial Intelligence In 2025 A McKinsey report characterizes 2023 as the year "the world discovered generative AI (gen AI)." 2024 is when businesses began realizing value from using gen AI. The rising adoption has sparked extreme demand for AI-capable computing power. Data centers, in turn, invested billions in hardware and software for powering, developing and training AI applications. In 2025, companies like OpenAI will look to move AI's capabilities into increasingly complex tasks. Use cases for AI will expand across industries and into the personal computing space. Organizations that have invested in AI will attempt to quantify the business value of those investments....
Read more

Did Steve Jobs Refuse Treatment for Pancreatic Cancer?

By Editorial Team -
Image
It’s been more than 12 years since the passing of Steve Jobs. Legendary Apple Inc., Co-founder Steve Jobs passed away at only 56 years old after battling pancreatic neuroendocrine tumor, a rare form of pancreatic cancer. A growing list of people in the public spotlight have faced pancreatic cancer, including tech innovators, entrepreneurs and influencers. In addition, and connected to Jobs, Jef Raskin, developer of the Macintosh computer, passed away of pancreatic cancer in 2005. And, coincidentally, Dag Kittlaus, creator of Siri, which was acquired by Apple in 2010, was diagnosed with the same exact cancer that took the life of Jobs. Pancreatic neuroendocrine tumors (or PNETs) account for less than 10% of all pancreatic cancer tumors and tend to grow slower than exocrine tumors, the most common type of pancreas tumors. Jobs survived eight years before dying of the disease on Oct. 5, 2011. The five-year survival rate for pancreatic cancer is only 10%. Since PNETs are so uncommon, trea...
Read more